Biohaven Ltd.
BHVN
$29.86
-$0.54-1.78%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -107.37% | -73.15% | -73.31% | 4.88% | 28.43% |
| Total Depreciation and Amortization | 13.64% | 35.92% | 62.63% | 140.90% | 398.70% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 432.76% | 90.49% | 77.73% | -64.37% | -85.02% |
| Change in Net Operating Assets | -31.70% | -56.36% | 75.04% | 270.92% | 186.05% |
| Cash from Operations | -75.58% | -80.18% | -63.87% | -12.71% | -11.43% |
| Capital Expenditure | -32.84% | -55.32% | 17.01% | 58.05% | 49.82% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 101.12% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -281.61% | -23.34% | 97.57% | 163.35% | 150.39% |
| Cash from Investing | -288.69% | -23.75% | 95.21% | 153.97% | 142.60% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 172.98% | 125.87% | 99.04% | -12.11% | -12.67% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.30% | -96.54% | -109.56% | -112.56% | -107.45% |
| Cash from Financing | 219.84% | 30.85% | -20.17% | -75.54% | -72.39% |
| Foreign Exchange rate Adjustments | 115.09% | -233.47% | -228.72% | -216.67% | -215.85% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,671.86% | -150.92% | -77.32% | -102.45% | -94.25% |
